S&P 500
(0.04%) 5 471.75 points
Dow Jones
(0.07%) 39 141 points
Nasdaq
(0.29%) 17 769 points
Oil
(-0.24%) $80.64
Gas
(-5.04%) $2.62
Gold
(-0.89%) $2 310.10
Silver
(-0.37%) $28.76
Platinum
(3.07%) $1 016.70
USD/EUR
(0.33%) $0.936
USD/NOK
(0.74%) $10.68
USD/GBP
(0.50%) $0.792
USD/RUB
(-0.28%) $87.25

Sanntidsoppdatering for POINT Biopharma Global [PNT]

Børs: NASDAQ Sektor: Healthcare Industri: Biotechnology
Sist oppdatert26 des 2023 @ 22:00

0.16% $ 12.50

Live Chart Being Loaded With Signals

Commentary (26 des 2023 @ 22:00):
Profile picture for POINT Biopharma Global Inc.

POINT Biopharma Global Inc., a radiopharmaceutical company, focuses on the development and commercialization of radioligands that fight cancer. Its lead product candidates include PNT2002, a prostate-specific membrane antigen (PSMA) targeted radioligand that is in Phase III trial for the treatment of metastatic castration-resistant prostate cancer; and PNT2003, a somatostatin-targeted radioligand, which is in Phase III trial for the treatment of neuroendocrine tumors...

Stats
Dagens volum 3.29M
Gjennomsnittsvolum 3.85M
Markedsverdi 1.33B
EPS $-0.230 ( Q3 | 2023-11-13 )
Neste inntjeningsdato ( $0 ) 2024-08-12
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E 11.36
(Sector) 42.63
(Industry) 24.32
ATR14 $0.322 (2.58%)
AADI -5.88%
ABCL 0.92%
ABCM 0.04%
ABEO -3.08%
ABIO -0.30%
ABOS 1.64%
ABSI 3.40%
ABUS -1.15%
ABVX -3.00%
ACAD -0.35%
ACER -17.95%
ACET -9.18%
ACGN 1.29%
ACHL -1.70%
ACHV 2.59%
ACIU -0.50%
ACLX -0.37%
ACRV -4.29%
ACST -3.58%
ACXP 3.69%
ADAG 7.14%
ADAP -3.71%
ADGI 0.87%
ADIL -2.66%
ADMA -1.14%
ADPT 0.44%
ADTX -3.47%
ADVM 1.30%
ADXN -1.60%
AEON -4.67%
AEZS -2.49%
AFMD -3.15%
AGEN -4.00%
AGIO -2.51%
AGLE 6.66%
AGTC 0.00%
AIKI 0.85%
AIMDW -13.88%
AKBA 8.24%
AKRO -2.26%
AKTX -5.23%
AKUS 0.00%
ALBO 0.00%
ALDX -2.10%
ALEC -0.80%
ALGS -0.37%
ALKS 1.99%
ALLK -11.39%
ALLO -2.50%
ALLR -1.63%
ALNA 3.16%
ALNY 2.08%
ALPN 0.02%
ALPX 0.00%
ALRN -2.63%
ALT -15.32%
ALVR -0.79%
ALXN 0.00%
ALXO -10.65%
ALZN 5.10%
AMRN -4.56%
AMTI -3.13%
ANAB 1.55%
ANEB 7.95%
ANGN 0.00%
ANIX -3.64%
ANL -0.14%
ANNX 3.71%
ANPC -3.15%
APGE 2.11%
APGN 8.48%
APGNW 30.65%
APLM -3.25%
APLS 0.35%
APLT 1.35%
APM 1.47%
APOP 0.38%
APRE -3.13%
APTO 0.62%
APTX 3.17%
APVO 3.21%
ARAV -13.39%
ARCT -6.62%
ARDS -12.13%
ARDX 2.24%
ARGX -0.79%
ARNA 0.00%
ARPO -0.90%
ARQT -3.33%
ARTL -2.50%
ARTLW 0.00%
ARVN 7.11%
ARWR -2.38%
ASLN -2.45%
ASMB -5.55%
ASND -2.24%
ATAI -3.33%
ATHA 7.76%
ATHE 0.08%
ATHX -33.50%
ATNF 2.18%
ATOS 5.37%
ATRA -6.30%
ATXI 1.09%
ATXS -0.33%
AUPH -0.72%
AURA 4.85%
AUTL -3.16%
AVBP -3.20%
AVEO 0.00%
AVIR -1.75%
AVRO -1.41%
AVTE -0.35%
AVTX -4.26%
AVXL -5.68%
AXLA 0.00%
AXSM -1.32%
AYLA 0.00%
AZRX 2.07%
BBI 2.17%
BBIO 1.30%
BCAB -6.89%
BCDA -0.85%
BCDAW -46.41%
BCEL 0.00%
BCLI 3.09%
BCRX 1.64%
BCTX 13.26%
BCTXW 1.97%
BCYC 1.15%
BDRX -5.56%
BDTX 0.21%
BEAM 2.60%
BFRA -2.91%
BGNE -2.91%
BIOR -3.83%
BIVI 2.38%
BLCM -6.68%
BLI -5.88%
BLPH 0.00%
BLRX -0.89%
BLTE -1.25%
BLU 0.03%
BLUE -4.84%
BMEA -15.34%
BMRN 0.15%
BNOX 4.46%
BNTC -2.95%
BNTX -2.10%
BOLD -11.17%
BOLT 0.33%
BPMC -2.33%
BPTH -4.05%
BPTS -13.47%
BRNS -0.37%
BRTX -5.90%
BTAI 13.62%
BTTX 20.00%
BTX 0.05%
BVXV 0.74%
BXRX 7.39%
BYSI 2.78%
CABA 1.18%
CADL 1.42%
CALA 0.00%
CALC -3.82%
CALT -1.59%
CAPR -0.43%
CARA -11.87%
CARM 6.36%
CASI -1.18%
CATB -6.97%
CBAY 0.03%
CBIO -2.65%
CBLI -7.31%
CBUS 1.45%
CCCC -1.59%
CCXI 0.00%
CDAK 0.00%
CDIO -4.66%
CDIOW 24.00%
CDMO -1.41%
CDMOP 0.04%
CDT -5.69%
CDTTW -39.60%
CDTX -6.36%
CDXC 9.63%
CDXS 9.66%
CELC -3.43%
CELU 0.74%
CELUW 11.80%
CERC -1.68%
CERE -1.45%
CERO -5.02%
CEROW -10.18%
CFRX -27.95%
CGEM 0.12%
CGEN -3.59%
CGON -2.64%
CGTX -3.41%
CHMA -6.00%
CHRS 4.75%
CINC 0.00%
CING -3.90%
CINGW 34.95%
CKPT -0.96%
CLBS -16.75%
CLDX -0.41%
CLGN -0.50%
CLLS -3.11%
CLNN -2.50%
CLNNW 0.00%
CLRB 6.47%
CLSD -2.40%
CLSN -0.68%
CLVS 0.00%
CMMB -2.94%
CMND 2.24%
CMPI 0.00%
CMPX 0.93%
CMRA 0.00%
CMRAW 33.33%
CMRX -4.43%
CNCE 0.00%
CNSP -34.50%
CNST 0.00%
CNTA 0.79%
CNTB -1.50%
CNTX -7.76%
COCP -1.83%
COEPW 32.45%
COGT -2.64%
CORT 3.39%
COYA -2.44%
CPRX -1.29%
CRBP -1.35%
CRBU -7.95%
CRDF 2.65%
CRGX -1.95%
CRIS -2.64%
CRNX -5.84%
CRSP 0.97%
CRTX 2.63%
CRVO -6.30%
CRVS 0.00%
CSBR -0.19%
CTCX 1.20%
CTIC 0.06%
CTMX -3.31%
CTNM 5.57%
CTXR -4.57%
CUE -2.42%
CVAC -4.95%
CVKD -2.34%
CWBR 2.80%
CYAD -12.96%
CYCC 18.13%
CYCCP 5.28%
CYCN 7.81%
CYT -2.27%
CYTK -2.97%
CYTO 0.00%
DARE 0.86%
DAWN -0.07%
DBTX -0.81%
DBVT 4.17%
DFFN 10.28%
DICE 0.06%
DMAC 31.86%
DNLI -1.79%
DNTH -2.20%
DOMH 1.06%
DRMA -2.57%
DRMAW -1.25%
DRNA 0.00%
DRTS 0.46%
DRTSW 0.00%
DRUG -0.10%
DSGN -2.42%
DTIL -0.21%
DYAI 9.68%
EARS -1.77%
EDIT -2.92%
EDSA 4.14%
EFTR 1.50%
EFTRW -51.85%
EIGR -9.21%
ELAB -3.01%
ELDN 7.14%
ELEV -1.24%
ELOX 10.77%
ELTX -3.38%
ELVN -1.49%
ELYM 5.44%
ENGN 0.49%
ENGNW -21.67%
ENLV -1.45%
ENOB 1.79%
ENSC 6.55%
ENTA -0.90%
ENTO -4.97%
ENTX 0.53%
ENVB -0.02%
EPIX -2.68%
EPRX -2.87%
EPZM 0.00%
EQ -1.24%
EQRX -2.09%
EQRXW 0.00%
ERAS 6.25%
ERNA -2.78%
ERYP 1.30%
ESLA 4.30%
ESLAW 16.64%
ETNB -6.01%
ETON 2.44%
ETTX 0.00%
EVAX 0.00%
EVGN 3.46%
EVLO 0.00%
EWTX 0.29%
EXAI -0.47%
EXEL 0.94%
EYEG -0.69%
EYEN 0.00%
EYPT -0.12%
FATE -12.23%
FBIO 0.90%
FBIOP 0.87%
FBLG -10.30%
FBRX -0.04%
FDMT -4.68%
FENC -2.66%
FGEN -9.83%
FHTX 8.59%
FIXX 0.77%
FMTX 0.00%
FNCH 0.00%
FOLD -1.72%
FREQ 4.76%
FRLN 0.15%
FRTX 0.00%
FSTX 0.00%
FTRE 0.76%
FULC 2.26%
FUSN 0.00%
FWBI 4.59%
FWP 0.00%
GALT 0.00%
GANX -1.54%
GBIO -1.06%
GBT 0.01%
GDTC 2.05%
GERN -1.66%
GHRS -4.27%
GLMD -2.48%
GLPG -1.79%
GLSI 9.27%
GLTO -3.86%
GLUE -2.37%
GLYC -15.08%
GMAB -0.37%
GMDA -18.25%
GMTX 0.00%
GNCA -85.71%
GNFT -2.34%
GNLX -3.98%
GNPX -4.41%
GNTA 3.94%
GOSS -7.73%
GOVX -6.36%
GOVXW 10.89%
GPCR -5.68%
GRAY -10.80%
GRCL 0.05%
GRNA -0.03%
GRNAW 8.91%
GRPH -2.75%
GRTS -2.16%
GRTX -1.66%
GTHX 2.27%
GUTS 0.12%
GXGXW 41.67%
GYRE -5.95%
HALO -0.92%
HARP 0.09%
HCWB -3.76%
HEPA -3.50%
HGEN -84.62%
HILS 5.66%
HLVX 0.15%
HOOK 1.19%
HOTH -3.67%
HOWL 0.43%
HRMY 3.16%
HRTX 8.36%
HSTO 0.00%
HUMA 1.98%
HUMAW -6.25%
IBRX -5.64%
ICCC -2.10%
ICPT 0.21%
ICU 20.03%
ICUCW 4.86%
ICVX -0.91%
IDRA -23.04%
IDYA -3.24%
IFRX -3.52%
IGMS -2.12%
IKNA -1.79%
IKT -2.08%
IMAB -0.58%
IMCR -3.27%
IMGN 0.02%
IMGO 0.00%
IMMP 5.51%
IMMX -3.88%
IMNM 3.72%
IMNN 1.77%
IMPL -27.27%
IMRA 15.96%
IMRN -0.40%
IMRX -3.50%
IMTX -1.25%
IMTXW 6.00%
IMUX -5.56%
IMV 0.00%
IMVT -3.99%
INAB -1.12%
INBX -3.11%
INCY -2.10%
INDP 6.88%
INFI -52.38%
INKT 0.00%
INM 3.06%
INMB 2.66%
INO 2.02%
INSM -0.92%
INTS -3.73%
INVA 0.81%
INZY 1.14%
IOBT -7.48%
IONS 1.68%
IOVA -3.84%
IPA 1.08%
IPHA 2.54%
IPSC -2.34%
IRON -1.88%
ISEE 0.38%
ITOS 3.01%
ITRM 1.36%
IVA 6.96%
IVVD 0.41%
JAGX 0.26%
JANX -4.94%
JAZZ -0.74%
JNCE 0.00%
JSPR -1.51%
JSPRW 20.88%
JUNS 0.00%
JUNSW 0.00%
KA -3.49%
KALV -2.42%
KDNY 0.22%
KMPH -0.34%
KNSA -2.48%
KNTE -0.38%
KOD -8.73%
KPRX -5.76%
KPTI -8.86%
KRBP -10.00%
KRON 1.61%
KROS -0.33%
KRRO -1.59%
KRTX 0.03%
KRYS 0.96%
KTRA 9.85%
KTTA -0.65%
KTTAW 0.92%
KURA 0.98%
KYMR -3.50%
KYTX -5.43%
KZIA 6.13%
KZR -1.77%
LABP 0.57%
LBPH 0.63%
LBPS 0.00%
LBPSW 14.81%
LEGN 3.15%
LENZ -3.21%
LEXX 0.58%
LEXXW -14.63%
LGND -0.82%
LGNDV 0.00%
LGVN -9.04%
LIAN -8.28%
LIFE 2.70%
LIPO -5.29%
LIXT -9.76%
LIXTW 46.21%
LJPC -0.32%
LMNL 0.12%
LOGC 0.43%
LPCN -4.36%
LPTX -1.10%
LQDA 0.24%
LRMR -0.50%
LSTA -1.68%
LTRN 5.49%
LUMO 0.67%
LVTX -5.10%
LXEO -12.98%
LXRX -1.18%
LYEL -36.03%
LYRA 4.19%
MACK 0.10%
MBIO -11.90%
MBRX -1.43%
MCRB 0.80%
MDGL -1.79%
MDNA -13.16%
MDWD 3.36%
MDXG -1.55%
MEIP 0.70%
MESO -1.48%
MGNX -5.13%
MGTA -7.74%
MGTX -0.71%
MGX -0.54%
MIRM -0.57%
MIRO 0.59%
MIST 1.92%
MITO 0.00%
MLEC -6.54%
MLECW 2.31%
MLND -5.36%
MLTX 0.88%
MLYS -8.42%
MNKD -0.67%
MNMD 2.76%
MNOV 1.41%
MNPR -9.34%
MOLN 0.76%
MOR 0.62%
MORF -2.77%
MREO 0.14%
MRKR -0.43%
MRNA -10.77%
MRNS -5.99%
MRSN -3.57%
MRTX -0.17%
MRUS 0.65%
MRVI 1.46%
MTCR -1.29%
MTEM 7.43%
MTP -18.50%
MURA -4.32%
MYMD 2.17%
NAMS -0.15%
NAMSW 0.64%
NAUT 1.11%
NBRV 0.71%
NBSE -1.56%
NBTX 8.91%
NCNA -0.18%
NERV -0.32%
NEXI 1.50%
NGM -1.28%
NGNE 3.57%
NKGN 10.92%
NKGNW -20.00%
NKTR 1.87%
NKTX -2.85%
NLSP 5.63%
NLSPW 26.67%
NMRA -1.26%
NMTR -42.97%
NOVN -24.84%
NRBO 14.85%
NRIX -1.44%
NRSN 0.78%
NRSNW 0.00%
NRXP -8.92%
NRXPW 18.33%
NRXS -1.20%
NTBL 2.63%
NTEC -12.45%
NTHI 0.00%
NTLA -4.67%
NTRBW -31.07%
NUVL -1.83%
NVAX -5.82%
NVCT -7.75%
NVIV -34.28%
NXTC -5.88%
NYMX -0.05%
OABI 3.03%
OABIW -10.06%
OBIO 0.00%
OBSV 0.00%
OCEA -4.23%
OCGN 7.20%
OCS -1.00%
OCUL 0.38%
OCUP 0.00%
ODT -4.27%
OKYO 1.72%
OLMA -4.60%
OMER -2.57%
OMGA -2.08%
ONCO 6.16%
ONCR -3.08%
ONCS 31.87%
ONCT -2.04%
ONCY 2.90%
ONTX -0.47%
ONVO 2.00%
OPNT 0.00%
OPT -5.15%
ORGS -0.69%
ORIC -3.56%
ORMP 16.29%
ORPH 0.00%
ORTX 0.30%
OSMT -1.77%
OTIC -92.64%
OTLK -0.28%
OVID 0.40%
OYST 0.00%
PALI -0.48%
PASG 0.00%
PBLA -7.50%
PBM -4.75%
PBYI 4.56%
PCSA 0.95%
PCVX 0.67%
PDSB -4.75%
PEPG 1.31%
PGEN -6.39%
PHAR 1.99%
PHAS 0.00%
PHAT 0.39%
PHIO -3.55%
PHIOW 36.47%
PHVS -6.50%
PHXM -5.20%
PIRS 0.11%
PKBO 0.00%
PKBOW 999 900.00%
PLRX -2.56%
PLUR 10.34%
PMN -5.55%
PMVP -1.49%
PNT 0.16%
PPBT 1.64%
PRAX 4.77%
PRDS 0.93%
PRLD -3.43%
PROG -3.47%
PROK 2.24%
PRQR 1.20%
PRTA -3.37%
PRTC 0.49%
PRTG 1.40%
PRTK 1.83%
PRVB 0.00%
PSTI -2.91%
PSTV -12.20%
PSTX -4.26%
PTCT 0.09%
PTE -0.82%
PTGX 0.91%
PTIXW -48.41%
PULM 1.56%
PXMD 4.76%
PYPD 1.71%
PYXS 4.58%
QLGN -5.84%
QNCX 2.23%
QNRX 0.84%
QSI -28.90%
QSIAW -9.44%
QTTB 3.66%
QURE -1.46%
RAIN -1.63%
RANI 4.28%
RAPT -1.78%
RARE 1.94%
RCKT -10.27%
REGN -0.16%
RENB -3.42%
REPL -2.27%
RETA 0.02%
REUN -0.89%
REVB -1.86%
REVBU 3.46%
REVBW 5.00%
RGLS -5.61%
RGNX -6.25%
RIGL -6.24%
RLAY -5.64%
RLMD -0.33%
RLYB -5.37%
RNA 2.46%
RNAC 0.58%
RNAZ -1.92%
RNXT 2.23%
ROIV -2.17%
ROIVW 4.56%
RPHM -1.86%
RPRX -0.74%
RPTX -1.17%
RUBY 2.70%
RVLP -32.05%
RVMD -0.46%
RVMDW -29.90%
RVNC -0.21%
RVPH -0.40%
RVPHW -5.28%
RXDX 0.09%
RXRX -6.13%
RYTM -5.71%
RYZB 0.02%
RZLT 3.10%
SABS -1.37%
SABSW -5.53%
SAGE -0.37%
SANA -2.21%
SAVA -4.18%
SAVAW 0.00%
SBBP 1.52%
SBTX 1.03%
SCNI 1.29%
SCPH 11.62%
SCPS 0.00%
SEEL -3.18%
SEER 0.29%
SELB -8.00%
SESN 7.29%
SGEN -0.07%
SGMO -5.08%
SGMT -4.83%
SGTX -2.56%
SIOX 22.63%
SLDB -2.33%
SLGL 5.23%
SLN -8.77%
SLNO 0.58%
SLRX 0.40%
SLS -3.85%
SMMT -3.31%
SNDX 2.46%
SNGX 3.40%
SNPX -2.77%
SONN -1.59%
SPPI -0.49%
SPRB -1.63%
SPRC -3.29%
SPRO 0.38%
SRNE 0.00%
SRPT -0.80%
SRRA 0.00%
SRRK -1.61%
SRZN -2.45%
STAB 0.00%
STOK -6.88%
STRO -1.34%
STSA 0.00%
STTK 7.03%
SURF -0.93%
SVRA -4.34%
SWTX 0.41%
SYBX 0.00%
SYRS -2.07%
TALS -0.73%
TARA -7.84%
TARS -2.13%
TBPH 0.18%
TCBP 5.49%
TCDA 0.00%
TCON -0.70%
TCRR 0.00%
TCRT 4.49%
TCRX -2.58%
TECH -1.19%
TENX -0.32%
TERN -6.62%
TFFP -11.17%
TGTX -7.92%
THRX 0.12%
TIL -1.22%
TLC 0.00%
TLSA -4.65%
TNGX -3.67%
TNXP -9.65%
TNYA -6.48%
TPST 5.10%
TRDA -4.81%
TRVI 1.92%
TRVN 3.15%
TSHA -17.04%
TSVT -4.20%
TTNP -6.05%
TVTX 3.90%
TYRA -7.51%
UBX -2.73%
UNCY -4.00%
URGN 3.85%
UTHR -0.42%
VACC 11.36%
VALN -3.15%
VAXX 118.75%
VBIV -0.79%
VBLT -8.77%
VCEL 1.65%
VCNX 9.30%
VCYT -0.95%
VERA -4.40%
VERU 1.51%
VERV -3.54%
VIGL 1.08%
VINC 2.81%
VIR -1.08%
VIRI -5.66%
VIRX 3.47%
VKTX -1.03%
VLON -13.04%
VNDA -2.93%
VOR -6.45%
VRCA 0.85%
VRDN -3.21%
VRNA -1.80%
VRPX 3.58%
VRTX -0.11%
VSTM 4.76%
VTGN -2.26%
VTVT 1.28%
VTYX -1.88%
VXRT -0.49%
VYGR -0.64%
VYNE -5.80%
VYNT 7.78%
WINT -2.72%
WVE -8.07%
XBIO 1.03%
XBIT 4.17%
XCUR 0.23%
XENE -0.86%
XERS 4.76%
XFOR 5.73%
XLO 3.06%
XLRN 0.00%
XNCR 0.26%
XOMA -8.36%
XOMAO -0.45%
XOMAP -0.82%
XRTX -7.96%
YMAB -1.72%
ZGNX 0.00%
ZIOP -0.88%
ZLAB -2.70%
ZNTL -1.07%
ZSAN 0.00%
Insider Trading
Date Person Action Amount type
2023-12-26 Goodman Jonathan R. Sell 41 872 Common Stock
2023-12-27 Goodman Jonathan R. Sell 35 872 Stock Option (Right to Buy)
2023-12-27 Goodman Jonathan R. Sell 25 000 Stock Option (Right to Buy)
2023-12-27 Goodman Jonathan R. Sell 25 614 Stock Option (Right to Buy)
2023-12-27 Goodman Jonathan R. Sell 44 749 Stock Option (Right to Buy)
INSIDER POWER
-79.61
Last 96 transactions
Buy: 3 517 450 | Sell: 10 366 533

Volum Korrelasjon

Lang: 0.24 (neutral)
Kort: -0.64 (weak negative)
Signal:(35.382) Neutral

POINT Biopharma Global Korrelasjon

10 Mest positive korrelasjoner
LVOX0.847
10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

POINT Biopharma Global Korrelasjon - Valuta/Råvare

The country flag 0.64
( weak )
The country flag 0.28
( neutral )
The country flag 0.61
( weak )
The country flag 0.44
( neutral )
The country flag 0.03
( neutral )
The country flag -0.77
( moderate negative )

POINT Biopharma Global Økonomi

Annual 2022
Omsetning: $226.58M
Bruttogevinst: $226.58M (100.00 %)
EPS: $1.040
FY 2022
Omsetning: $226.58M
Bruttogevinst: $226.58M (100.00 %)
EPS: $1.040
FY 2021
Omsetning: $0.00
Bruttogevinst: $0.00 (0.00 %)
EPS: $-1.181
FY 2020
Omsetning: $0.00
Bruttogevinst: $0.00 (0.00 %)
EPS: $-0.00801

Financial Reports:

No articles found.

POINT Biopharma Global Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

POINT Biopharma Global

POINT Biopharma Global Inc., a radiopharmaceutical company, focuses on the development and commercialization of radioligands that fight cancer. Its lead product candidates include PNT2002, a prostate-specific membrane antigen (PSMA) targeted radioligand that is in Phase III trial for the treatment of metastatic castration-resistant prostate cancer; and PNT2003, a somatostatin-targeted radioligand, which is in Phase III trial for the treatment of neuroendocrine tumors. The company is also developing PNT2001, a next-generation PSMA-targeting product candidate for the treatment of non-metastatic castration sensitive prostate cancer, which is under preclinical studies; and PNT-2004, a fibroblast activation protein-a targeting program being developed for use in multiple tumor types that is under preclinical studies. In addition, it has product candidates being developed on CanSEEK technology sub-licensed from both Bach Biosciences LLC and Avacta Life Sciences Limited. POINT Biopharma Global Inc. was founded in 2019 and is headquartered in Indianapolis, Indiana.

Om Live Signaler

Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.

Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.

Total Execution Time: 2.1129992008209 seconds
Number of API calls: 3
Number of DB calls: 9